Candel Therapeutics, Inc. Liquidation Value

CADL Other

Cash & Equivalents

$119.73M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $119.73M
Total Obligations: -$107.02M
$12.71M
Per share: $0.23
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $119.73M
AR: $0
Total Obligations: -$107.02M
$12.71M
Per share: $0.23
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $119.73M
AR: $0
Inventory: $0
Total Obligations: -$107.02M
$12.71M
Per share: $0.23
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$12.71M$0.23
Liquid Liquidation Value$12.71M$0.23
Operating Liquidation Value$12.71M$0.23

Key Components (as of 2025-12-31)

Cash & Equivalents$119.73M
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$9.00M
Long-term Debt$96.12M
Op. Lease Liability$1.90M
Finance LeaseN/A
Shares Outstanding54.9M

Explore all 160 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$119.73MN/AN/A$1.13M$9.00M$96.12M$1.90MN/A
2025-09-30$86.96MN/AN/A$1.12M$10.93M$7.56M$2.01MN/A
2025-06-30$100.69MN/AN/A$1.95M$14.71M$12.54M$698,000N/A
2025-03-31$92.17MN/AN/A$760,000$20.07M$17.50M$837,000N/A
2024-12-31$102.65MN/AN/A$237,000$37.53M$1.73M$973,000N/A
2024-09-30$16.56MN/AN/A$296,000$15.27M$4.22M$1.11MN/A
2024-06-30$21.45MN/AN/A$433,000$14.00M$6.71M$1.24MN/A
2024-03-31$25.71MN/AN/A$472,000$13.54M$9.17M$1.36MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-12 View
2025-09-30 10-Q 2025-11-13 View
2025-06-30 10-Q 2025-08-14 View
2025-03-31 10-Q 2025-05-13 View
2024-12-31 10-K 2025-03-13 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-Q 2024-08-13 View
2024-03-31 10-Q 2024-05-14 View

Community Notes

Loading notes...

Questions

Loading questions...